Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
15-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
15-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #38862
advertisement
Kagemann L
3
Showing records 1 to 3 |
Display all abstracts from
Kagemann L
55456
In vivo lamina cribrosa micro-architecture in healthy and glaucomatous eyes as assessed by optical coherence tomography
Wang B; Nevins JE; Nadler Z; Wollstein G; Ishikawa H; Bilonick RA; Kagemann L; Sigal IA; Grulkowski I; Liu JJ; Kraus M; Lu CD; Hornegger J; Fujimoto JG; Schuman JS
Investigative Ophthalmology and Visual Science
2013; 54: 8270-8274
55752
Reproducibility of In-Vivo OCT Measured Three-Dimensional Human Lamina Cribrosa Microarchitecture
Wang B; Nevins JE; Nadler Z; Wollstein G; Ishikawa H; Bilonick RA; Kagemann L; Sigal IA; Grulkowski I; Liu JJ; Kraus M; Lu CD; Hornegger J; Fujimoto JG; Schuman JS
PLoS ONE
2014; 9: e95526
55187
Signal normalization reduces systematic measurement differences between spectral-domain optical coherence tomography devices
Chen CL; Ishikawa H; Ling Y; Wollstein G; Bilonick RA; Xu J; Fujimoto JG; Sigal IA; Kagemann L; Schuman JS
Investigative Ophthalmology and Visual Science
2013; 54: 7317-7322
Issue
15-4
Table of Contents
Editor's Selection
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept